|
RPRX | Royalty Pharma Plc |
|
|
RPRX | Royalty Pharma Plc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 1.58 |
| Leverage | 43.62% |
| Market Cap | $ 19.3B |
| PE | 17.79 |
| Dividend Yield | 2.61% |
| Profit | $ 1.1B |
| Margin | 48.15% |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. The company is headquartered in New York, New York.